Fireside Chat & Beer Tasting Evening Hosted by Quotient Sciences at CPhI Frankfurt

Frankfurt am Main, Germany | 29 October 2025
Overview

Join us for an exclusive evening of insightful discussion, premium craft beer, and gourmet canapés during CPhI Worldwide 2025 in Frankfurt. 

Hosted by Quotient Sciences, this relaxed networking event will bring together industry professionals and thought leaders to explore the future of drug development. Expect engaging conversations around cutting-edge topics such as challenges in CMC in modern pharmaceutical development, AI-driven formulation development and the expanding role of mRNA-based therapies. 

Whether you're looking to connect with peers, gain fresh insights, or simply unwind after a busy day at the conference, this evening promises to be both informative and enjoyable.

Key learning objectives:

  • Understand emerging trends in drug development and their impact on the pharmaceutical development process
  • Explore developments in the application of AI in formulation development
  • Gain insights into the challenges associated with development of mRNA-based therapies, and opportunities for supply chain innovation
  • Expand professional networks through meaningful conversations with peers and industry leaders
Date/TimeLocation

Wednesday, 29th October, 2025

5:30 PM - 6:15 PM - Arrival/Registration

6:15 PM - 7:30 PM - Fireside Chat

7:30 PM - 9:30 PM – Networking, Canapes and Beer tasting

Frankfurt Marriott Hotel

Hamburger Allee 2,
60486 Frankfurt am Main, Germany

Space is limited! Register your interest to attend our seminar. If you have any questions or difficulty registering, reach out to [email protected].

 

*We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.

Register
Location
Frankfurt Marriott Hotel
Hamburger Allee 2, 60486
Frankfurt am Main, Germany

Meet our expert:

We look forward to meeting you at Fireside Chat & Beer Tasting Evening Hosted by Quotient Sciences at CPhI Frankfurt.

Dr. Philippe Lienard

Founder, AB Consulting CMC and Technology, formerly of Sanofi and Institut Pasteur

Dr. Brendan Fish

Director of Biologics and RNA Centre of Excellence, UK Centre for Process Innovation

Thierry Van Nieuwenhove

CEO

Thierry Van Nieuwenhove, CEO, joined Quotient Sciences in October 2023. He succeeds Mark Egerton as CEO, who retired after 18 year...

About Thierry
John McDermott

VP, Scientific Consulting

John McDermott leads Quotient Sciences' global drug development consulting, research fellows, modeling & simulation, and clien...

About John

More insight from our experts:

Read More
Drug Product, Commercial Manufacturing, Clinical Trial Manufacturing, Translational Pharmaceutics, Regulatory, Orphan Rare, FDA Navigating Expedited Drug Development Pathways Globally: Q&A with Quotient Sciences Experts
Read More
Drug Development Consulting, Translational Pharmaceutics, Formulation Development, Drug Product, Careers The Strategic Role of Drug Development Consultants at Quotient Sciences
Read More
Translational Pharmaceutics, Formulation Development, Peptides, Dr. Andrew Lewis Using a formulation design space with Translational Pharmaceutics® for success in oral peptide development
Read More
Get in touch
Humanity can't afford to wait, so neither can we.